ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 178 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -33.3% | 1,360 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $6 | 0.0% | 1,360 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6 | -25.0% | 1,360 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $8 | -99.9% | 1,360 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $14,000 | -60.0% | 1,360 | -56.1% | 0.00% | -50.0% |
| Q2 2022 | $35,000 | -63.2% | 3,100 | -72.4% | 0.00% | -60.0% |
| Q1 2022 | $95,000 | -5.0% | 11,242 | -18.2% | 0.01% | +25.0% |
| Q4 2021 | $100,000 | +132.6% | 13,742 | +708.4% | 0.00% | +100.0% |
| Q3 2021 | $43,000 | -12.2% | 1,700 | -32.0% | 0.00% | 0.0% |
| Q2 2021 | $49,000 | +250.0% | 2,500 | +525.0% | 0.00% | +100.0% |
| Q1 2021 | $14,000 | -26.3% | 400 | -91.8% | 0.00% | 0.0% |
| Q3 2020 | $19,000 | -50.0% | 4,900 | +4.3% | 0.00% | -50.0% |
| Q2 2020 | $38,000 | – | 4,700 | +4600.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 100 | -98.3% | 0.00% | -100.0% |
| Q3 2019 | $30,000 | – | 5,900 | +1866.7% | 0.00% | – |
| Q2 2019 | $0 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |